A carregar...
Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26
BACKGROUND: Recurrence of colorectal cancer (CRC) may arise due to the persistence of drug-resistant and cancer-initiating cells that survive exposure to chemotherapy. Proteins responsible for this recurrence include the chemokine receptor CXCR4, which is known to enable CRC metastasis, as well as t...
Na minha lista:
Publicado no: | BMC Cancer |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4640216/ https://ncbi.nlm.nih.gov/pubmed/26552750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1702-2 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|